- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Abbott India
Market Cap: ₹543.3b
Operates as a pharmaceutical company in India.
500488
₹25,566.95
7D
-0.1%
1Y
-27.8%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹417.3b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,463.40
7D
4.6%
1Y
-25.3%
Sanofi India
Market Cap: ₹79.6b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,455.60
7D
1.7%
1Y
-43.4%